Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is somewhat ambitious. Besides puttering about the grounds and promenading with the official mascot, we plan to visit the Pharmalot ancestors and catch up on our reading. And what about you? This is a fine time to enjoy the great outdoors — beaches, lakes, and mountains are beckoning. You could also plan a summer getaway. Or make plans to take in a ball game or outdoor concert. Well, whatever you do, have a grand time. But be safe. And if dad is around, remember to say hello. …

Two-thirds of Americans who are familiar with the details of the newly approved Alzheimer’s treatment believe the medication will be effective, but a similar percentage have concerns about the regulatory process used to endorse the drug and people are divided over whether the drug, which will cost $56,000, is fairly priced, according to a new survey from STAT and The Harris Poll. Among those who had only heard about the approval, slightly more than half agree the drug will be effective.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment